{"pmid":32380217,"pmcid":"PMC7198179","title":"The COVID-19 crisis: A unique opportunity to expand dermatology to underserved populations.","text":["The COVID-19 crisis: A unique opportunity to expand dermatology to underserved populations.","J Am Acad Dermatol","Ashrafzadeh, Sepideh","Nambudiri, Vinod E","32380217"],"journal":"J Am Acad Dermatol","authors":["Ashrafzadeh, Sepideh","Nambudiri, Vinod E"],"date":"2020-05-08T11:00:00Z","year":2020,"_id":"32380217","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.jaad.2020.04.154","keywords":["covid-19","centers for medicare & medicaid","health care access","health policy","healthcare disparities","teledermatology","underserved"],"topics":["Prevention"],"weight":1,"_version_":1666262687572557824,"score":9.490897,"similar":[{"pmid":32380220,"pmcid":"PMC7198184","title":"Invited Commentary on the letter \"The COVID-19 crisis: A unique opportunity to expand dermatology to underserved populations.\"","text":["Invited Commentary on the letter \"The COVID-19 crisis: A unique opportunity to expand dermatology to underserved populations.\"","J Am Acad Dermatol","Kovarik, Carrie","Lee, Ivy","Tejasvi, Trilokraj","Lipoff, Jules B","32380220"],"journal":"J Am Acad Dermatol","authors":["Kovarik, Carrie","Lee, Ivy","Tejasvi, Trilokraj","Lipoff, Jules B"],"date":"2020-05-08T11:00:00Z","year":2020,"_id":"32380220","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.jaad.2020.04.155","weight":0,"_version_":1666262687605063681,"score":146.96136},{"pmid":32429920,"title":"Mobile health clinic model in the COVID-19 pandemic: lessons learned and opportunities for policy changes and innovation.","text":["Mobile health clinic model in the COVID-19 pandemic: lessons learned and opportunities for policy changes and innovation.","BACKGROUND: Mobile Clinics represent an untapped resource for our healthcare system. The COVID-19 pandemic has exacerbated its limitations. Mobile health clinic programs in the US already play important, albeit under-appreciated roles in the healthcare system. They provide access to healthcare especially for displaced or isolated individuals; they offer versatility in the setting of a damaged or inadequate healthcare infrastructure; and, as a longstanding community-based service delivery model, they fill gaps in the healthcare safety-net, reaching social-economically underserved populations in both urban and rural areas. Despite an increasing body of evidence of the unique value of this highly adaptable model of care, mobile clinics are not widely supported. This has resulted in a missed opportunity to deploy mobile clinics during national emergencies such as the COVID-19 pandemic, as well as using these already existing, and trusted programs to overcome barriers to access that are experienced by under-resourced communities. MAIN TEXT: In March, the Mobile Healthcare Association and Mobile Health Map, a program of Harvard Medical School's Family Van, hosted a webinar of over 300 mobile health providers, sharing their experiences, challenges and best practices of responding to COVID 19. They demonstrated the untapped potential of this sector of the healthcare system in responding to healthcare crises. A Call to Action: The flexibility and adaptability of mobile clinics make them ideal partners in responding to pandemics, such as COVID-19. In this commentary we propose three approaches to support further expansion and integration of mobile health clinics into the healthcare system: First, demonstrate the economic contribution of mobile clinics to the healthcare system. Second, expand the number of mobile clinic programs and integrate them into the healthcare infrastructure and emergency preparedness. Third, expand their use of technology to facilitate this integration. CONCLUSIONS: Understanding the economic and social impact that mobile clinics are having in our communities should provide the evidence to justify policies that will enable expansion and optimal integration of mobile clinics into our healthcare delivery system, and help us address current and future health crises.","Int J Equity Health","Attipoe-Dorcoo, Sharon","Delgado, Rigoberto","Gupta, Aditi","Bennet, Jennifer","Oriol, Nancy E","Jain, Sachin H","32429920"],"abstract":["BACKGROUND: Mobile Clinics represent an untapped resource for our healthcare system. The COVID-19 pandemic has exacerbated its limitations. Mobile health clinic programs in the US already play important, albeit under-appreciated roles in the healthcare system. They provide access to healthcare especially for displaced or isolated individuals; they offer versatility in the setting of a damaged or inadequate healthcare infrastructure; and, as a longstanding community-based service delivery model, they fill gaps in the healthcare safety-net, reaching social-economically underserved populations in both urban and rural areas. Despite an increasing body of evidence of the unique value of this highly adaptable model of care, mobile clinics are not widely supported. This has resulted in a missed opportunity to deploy mobile clinics during national emergencies such as the COVID-19 pandemic, as well as using these already existing, and trusted programs to overcome barriers to access that are experienced by under-resourced communities. MAIN TEXT: In March, the Mobile Healthcare Association and Mobile Health Map, a program of Harvard Medical School's Family Van, hosted a webinar of over 300 mobile health providers, sharing their experiences, challenges and best practices of responding to COVID 19. They demonstrated the untapped potential of this sector of the healthcare system in responding to healthcare crises. A Call to Action: The flexibility and adaptability of mobile clinics make them ideal partners in responding to pandemics, such as COVID-19. In this commentary we propose three approaches to support further expansion and integration of mobile health clinics into the healthcare system: First, demonstrate the economic contribution of mobile clinics to the healthcare system. Second, expand the number of mobile clinic programs and integrate them into the healthcare infrastructure and emergency preparedness. Third, expand their use of technology to facilitate this integration. CONCLUSIONS: Understanding the economic and social impact that mobile clinics are having in our communities should provide the evidence to justify policies that will enable expansion and optimal integration of mobile clinics into our healthcare delivery system, and help us address current and future health crises."],"journal":"Int J Equity Health","authors":["Attipoe-Dorcoo, Sharon","Delgado, Rigoberto","Gupta, Aditi","Bennet, Jennifer","Oriol, Nancy E","Jain, Sachin H"],"date":"2020-05-21T11:00:00Z","year":2020,"_id":"32429920","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1186/s12939-020-01175-7","keywords":["covid-19 pandemic","emergency preparedness","mobile clinics","underserved"],"locations":["US"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Prevention"],"weight":1,"_version_":1667342288305520641,"score":80.01953},{"pmid":32370981,"title":"[Evolution of electro-convulsive therapy activity in France since the beginning of the COVID-19 pandemic].","text":["[Evolution of electro-convulsive therapy activity in France since the beginning of the COVID-19 pandemic].","The recent COVID-19 pandemic has led to major organisational changes in health care settings, especially in psychiatric hospitals. We conducted a national online survey to assess the evolution of electroconvulsive therapy (ECT) in the different centres practicing this treatment. 65 responses from all over France were analysed. More than 90 % of the centres practising ECT experienced a decrease in their activity. Half of the centres experienced a total cessation of activity and 25 % of the centres experienced a decrease of more than half of their usual activity. Post-pandemic COVID-19 psychiatric care is expected to be difficult. It is essential not to add to this difficulty the complications, often serious, that will be associated with delaying or stopping the practice of ECT. It will also be necessary to remain vigilant with regard to the specific neuropsychiatric consequences that will follow the pandemic.","Encephale","Amad, A","Magnat, M","Quiles, C","Yrondi, A","Sauvaget, A","Bulteau, S","Plaze, M","Rotharmel, M","Polosan, M","Levy-Chavagnat, D","Jaafari, N","Vaiva, G","Thomas, P","32370981"],"abstract":["The recent COVID-19 pandemic has led to major organisational changes in health care settings, especially in psychiatric hospitals. We conducted a national online survey to assess the evolution of electroconvulsive therapy (ECT) in the different centres practicing this treatment. 65 responses from all over France were analysed. More than 90 % of the centres practising ECT experienced a decrease in their activity. Half of the centres experienced a total cessation of activity and 25 % of the centres experienced a decrease of more than half of their usual activity. Post-pandemic COVID-19 psychiatric care is expected to be difficult. It is essential not to add to this difficulty the complications, often serious, that will be associated with delaying or stopping the practice of ECT. It will also be necessary to remain vigilant with regard to the specific neuropsychiatric consequences that will follow the pandemic."],"journal":"Encephale","authors":["Amad, A","Magnat, M","Quiles, C","Yrondi, A","Sauvaget, A","Bulteau, S","Plaze, M","Rotharmel, M","Polosan, M","Levy-Chavagnat, D","Jaafari, N","Vaiva, G","Thomas, P"],"date":"2020-05-07T11:00:00Z","year":2020,"_id":"32370981","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.encep.2020.04.004","keywords":["acces aux soins","covid-19","complications","electroconvulsive therapy","epidemiology","health care access","pandemie","electro-convulsivo-therapie","epidemiologie"],"locations":["France","France"],"countries":["France"],"countries_codes":["FRA|France"],"topics":["Prevention"],"weight":1,"_version_":1666138496458293249,"score":66.99229},{"pmid":32298514,"title":"Noncutaneous considerations of COVID-19 for dermatology practices.","text":["Noncutaneous considerations of COVID-19 for dermatology practices.","COVID-19 presents many pressing challenges to the global dermatological community and our patients with ongoing skin needs, which must be considered by every dermatology provider. Many of these are logistical and administrative, distinct from physical manifestations, and could be summarized by the acronym COVID (Consultations, Operations, Videoconferencing, Immunosuppressive medications, Drug and equipment shortages). While the pandemic may represent a threat to many parts of our existence, dermatologists can help the patients we care for by considering noncutaneous implications of COVID-19 upon our practice.","J Cosmet Dermatol","Ali, Faisal R","Al-Niaimi, Firas","32298514"],"abstract":["COVID-19 presents many pressing challenges to the global dermatological community and our patients with ongoing skin needs, which must be considered by every dermatology provider. Many of these are logistical and administrative, distinct from physical manifestations, and could be summarized by the acronym COVID (Consultations, Operations, Videoconferencing, Immunosuppressive medications, Drug and equipment shortages). While the pandemic may represent a threat to many parts of our existence, dermatologists can help the patients we care for by considering noncutaneous implications of COVID-19 upon our practice."],"journal":"J Cosmet Dermatol","authors":["Ali, Faisal R","Al-Niaimi, Firas"],"date":"2020-04-17T11:00:00Z","year":2020,"_id":"32298514","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1111/jocd.13444","keywords":["covid-19","coronavirus","dermatology","teledermatology"],"locations":["Videoconferencing"],"topics":["Prevention"],"weight":1,"_version_":1666138493338779648,"score":64.18176},{"pmid":32441360,"title":"Evaluation Of Dermatology Consultations In The Era Of COVID19.","text":["Evaluation Of Dermatology Consultations In The Era Of COVID19.","It has been reported that dermatology practices may be a vector for SARS-CoV-2 transmission and elective cases should be postponed during the pandemic period. In this context, studies on the change of patient profile in Dermatology outpatient clinic have been conducted. However, there was no study in the literature about dermatology consultations during the pandemic period. 147 Dermatology consultation cases in the era of COVID-19 pandemic between March 11, 2020 and May 4, 2020 were retrospectively evaluated. 24 patients (16.3%) had suspicion and signs of COVID during consultation (fever, cough, shortness of breath, etc.). 9 (37.5%) of these patients also had accompanying COVID-19 skin lesions (2 urticarial lesions, 2 livedo and necrosis, 2 maculopapular eruption, 2 vesicular rashes, 1 pseudo-chilblain). The number of cases that were suspected to have COVID-19 was statistically significantly higher in consultations requested by the emergency department and intensive care unit, while there were no suspected cases in outpatient clinic consultations (P = 0.001). 2 (1.4%) of these patients were diagnosed with COVID-19 confirmed by PCR within 2 weeks. We acknowledge that daily practice changes frequently during this period, but still our study provides a perspective to other dermatology clinics in terms of the requested dermatology consultations during the pandemic. This article is protected by copyright. All rights reserved.","Dermatol Ther","Temiz, Selami Aykut","Dursun, Recep","Daye, Munise","Ataseven, Arzu","32441360"],"abstract":["It has been reported that dermatology practices may be a vector for SARS-CoV-2 transmission and elective cases should be postponed during the pandemic period. In this context, studies on the change of patient profile in Dermatology outpatient clinic have been conducted. However, there was no study in the literature about dermatology consultations during the pandemic period. 147 Dermatology consultation cases in the era of COVID-19 pandemic between March 11, 2020 and May 4, 2020 were retrospectively evaluated. 24 patients (16.3%) had suspicion and signs of COVID during consultation (fever, cough, shortness of breath, etc.). 9 (37.5%) of these patients also had accompanying COVID-19 skin lesions (2 urticarial lesions, 2 livedo and necrosis, 2 maculopapular eruption, 2 vesicular rashes, 1 pseudo-chilblain). The number of cases that were suspected to have COVID-19 was statistically significantly higher in consultations requested by the emergency department and intensive care unit, while there were no suspected cases in outpatient clinic consultations (P = 0.001). 2 (1.4%) of these patients were diagnosed with COVID-19 confirmed by PCR within 2 weeks. We acknowledge that daily practice changes frequently during this period, but still our study provides a perspective to other dermatology clinics in terms of the requested dermatology consultations during the pandemic. This article is protected by copyright. All rights reserved."],"journal":"Dermatol Ther","authors":["Temiz, Selami Aykut","Dursun, Recep","Daye, Munise","Ataseven, Arzu"],"date":"2020-05-23T11:00:00Z","year":2020,"_id":"32441360","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1111/dth.13642","keywords":["covid-19","dermatology consultation","pandemic","teledermatology"],"topics":["Prevention"],"weight":1,"_version_":1667535119503589376,"score":64.18176}]}